Influenza virus sialidase - A drug discovery target /

<p>Influenza continues to be an ongoing problem despite the existence of vaccines and drugs. Disease outbreaks can occur relatively quickly as witnessed with the recent emergence of the influenza virus A/H1N1 pandemic. The development of new anti-influenza drugs is thus a major challenge. <...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Korporativna značnica: SpringerLink (Online service)
Drugi avtorji: Itzstein, Mark
Format: eKnjiga
Jezik:English
Izdano: Basel : Springer Base, 2012.
Serija:Milestones in Drug Therapy
Teme:
Online dostop:Click here to view the full text content
Oznake: Označite
Brez oznak, prvi označite!
Opis
Izvleček:<p>Influenza continues to be an ongoing problem despite the existence of vaccines and drugs. Disease outbreaks can occur relatively quickly as witnessed with the recent emergence of the influenza virus A/H1N1 pandemic. The development of new anti-influenza drugs is thus a major challenge. </p><p>This volume describes all aspects of the virus structure and function relevant to infection. The focus is on drug discovery of inhibitors to the enzyme sialidase, which plays a key role in the infectious lifecycle of the virus. Following an overview of the influenza virus, the<b> </b>haemagglutinin, the interactions with the cell receptors and the enzymology of virus sialidase, recent results in drug design are presented. These include a full coverage of the design, synthesis and evaluation of carbohydrate as well as non-carbohydrate influenza virus sialidase inhibitors. Further reviews of the clinical experience with influenza virus sialidase inhibitors and of the development of resistance to these inhibitor drugs complement the topic.</p>
Fizični opis:1 Online resource (IX, 178 pages) 58 illustration, 21 illustration in color, digital.
ISBN:9783764389277